Russell Rosenblatt, M.D., M.S.
Transplant Hepatology
< Back to Search Results

Russell Rosenblatt, M.D., M.S.

Transplant Hepatology

Profile Photo of Russell Rosenblatt, M.D., M.S.
Accepts New Patients
Video Visit Icon Video Visits Available
Gender: Male
Language: English


Personal Statement

I am very excited to be a part of the Weill Cornell Medicine Division of Gastroenterology and Hepatology as a transplant hepatologist. My interest in the field of transplantation began in 1986, when my grandfather received a life-saving heart transplant. He lived 27 great years after this and was able to watch me graduate medical school, become a doctor, and dance at my wedding. I saw what a transplant can do. When I began my residency at Columbia University Medical Center, I was fascinated and challenged by the complexity of patients with liver disease. I knew I wanted to be a combine my two passions, transplantation and liver disease, within a few months of becoming a doctor. Being a transplant hepatologist allows me to care for and form a lifelong bond with a patient and their family. I consider it a great honor and privilege that I get to care for patients with liver disease and give them more time to spend with their loved ones.

My clinical practice focuses on liver disease and transplantation. I have a special interest in primary sclerosing cholangitis, a disease of the bile ducts that can cause significant complications for many patients both young and old. My research focuses on identifying risk factors for multi-drug resistant infections, which are quite common in patients with primary sclerosing cholangitis, and liver disease.

Specialties and Expertise


  • Hepatology
  • Transplant Hepatology


  • Liver Transplant
  • Hepatitis
  • Liver Cancer
  • Bile Duct Cancer
  • Autoimmune Disease
  • Liver Cirrhosis
  • Cirrhosis of Liver
  • Liver Disease Due to Alcohol
  • Liver Transplant Evaluation
  • PSC (Primary Sclerosing Cholangitis)
  • Primary Sclerosing Cholangitis
  • Primary Biliary Cholangitis
  • Hepatocellular Carcinoma


Dr. Russell Rosenblatt is an Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at Weill Cornell Medicine in New York City.  He specializes management of patients with liver diseases including autoimmune liver disease, viral hepatitis B and C, fatty liver disease, metabolic liver disease, and liver cancers. He sees patients with end-stage liver disease (cirrhosis) and evaluates those who need liver transplantation. He provides medical care to patients before and after liver transplantation. He has a special interest in the care of patients with primary sclerosing cholangitis.

He received his undergraduate Bachelor of Science in Physiology and Neurobiology from the University of Maryland in College Park, where he was a College Park Scholar, and graduated from the State University of New York Downstate College of Medicine in Brooklyn, New York, where he was inducted into the Alpha Omega Alpha Honor Medical Society. In 2014, he completed his internal medicine residency at Columbia University Medical Center in New York, New York and was a clinical instructor of medicine as a hospitalist from 2014-2015. He completed his gastroenterology fellowship training at Weill Cornell Medicine in 2018, where he served as chief gastroenterology fellow, and completed a Master’s of Science in Healthcare Policy and Economics the same year. He received the AASLD Advanced/Transplant Hepatology Fellow Award in 2018. He completed his transplant hepatology fellowship at Columbia University Medical Center and Weill Cornell Medicine in 2019.



Board Certifications

  • American Board of Internal Medicine
  • American Board of Internal Medicine (Gastroenterology)

Clinical and Academic Positions

  • Assistant Professor of Medicine - Weill Cornell Medical College, Cornell University
  • Adjunct Assistant Professor of Medicine - Columbia University College of Physicians and Surgeons

Education and Training

  • M.D., State University of New York Health Science Center at Brooklyn, 2011
  • B.S., University of Maryland, 2007


Insurance Plans Accepted

The following represents most of the managed care plans accepted by this doctor. If your insurance carrier does not appear here please contact the doctor’s office as they may have individual contracts not included on this site.

* indicates this doctor is no longer accepting new patients with this insurance plan.

  • AETNA - Medicare
  • Aetna Weill Cornell Employee Managed Care Plan
  • Aetna Weill Cornell Employee PPO Plan
  • Aetna-NYP - EPO/POS
  • Affinity Access
  • Affinity Health Plan
  • AgeWell New York
  • Amida Care
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield - Blue Access
  • Empire Blue Cross/Blue Shield - Blue Connection
  • Empire Blue Cross/Blue Shield - EPO
  • Empire Blue Cross/Blue Shield - HMO
  • Empire Blue Cross/Blue Shield - Mediblue (Senior)
  • Empire Blue Cross/Blue Shield - PPO
  • Empire Blue Cross/Blue Shield HealthPlus
  • Empire Blue Cross/Blue Shield HealthPlus - CHP
  • Fidelis Care
  • GHI - CBP
  • Health First
  • Health Insurance Plan of NY (HIP)
  • Health Insurance Plan of NY (HIP) - Medicaid
  • Health Insurance Plan of NY (HIP) - Medicare
  • Medicaid
  • Medicare
  • Oxford Health Plans - Freedom
  • Oxford Health Plans - Liberty
  • Oxford Health Plans - Medicare Advantage
  • Oxford Health Plans - Metro/Core/Charter
  • Rockefeller University - Trustmark
  • United Empire
  • United Healthcare
  • United Healthcare - Community Plan
  • United Healthcare - Medicare
  • United Healthcare Compass
  • VNSNY CHOICE - Medicare
  • WellCare of NY
  • WorldWide Medical

Locations and Appointments

External Relationships

External Relationships

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

No External Relationships Reported